Sandra Santarossa

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

Robert J. Motzer, Camillo Porta, Masatoshi Eto et al. · Journal of Clinical Oncology · 2024 · 158 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study

Orazio Caffo, Ugo De Giorgi, Lucia Fratino et al. · European Urology · 2014 · 83 citations · Full text

Medicine, Oncology, Urology +12

Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience

Alessandra Bearz, Renato Talamini, Gilda Rossoni et al. · BMC Research Notes · 2012 · 50 citations · Full text

Medicine, Oncology, Pharmacotherapy +8

Solitary meningeal recurrence in a patient with transitional cell carcinoma of the bladder with locally bulky disease at presentation

Sandra Santarossa, Emanuela Vaccher, Luca Balestreri et al. · Journal of Neuro-Oncology · 1997 · 13 citations

Medicine, Oncology, Urology +9

CONCOMITANT CHOP CHEMOTHERAPY (CT) AND HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IN PATIENTS (PTS) WITH HIV-RELATED NON-HODGKIN'S LYMPHOMA (HIV-NHL).

Emanuela Vaccher, Michele Spina, Renato Talamini et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 1998 · 12 citations

Medicine, Oncology, Pharmacotherapy +12